Japan Blood-based Biomaker For Sports Medicine Market Size & Outlook
Japan blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Japan blood-based biomaker for sports medicine market highlights
- The Japan blood-based biomaker for sports medicine market generated a revenue of USD 28.9 million in 2023 and is expected to reach USD 54.3 million by 2030.
- The Japan market is expected to grow at a CAGR of 9.4% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 28.9 million |
| Market revenue in 2030 | USD 54.3 million |
| Growth rate | 9.4% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Japan accounted for 4.3% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 17.99% in 2023. Horizon Databook has segmented the Japan blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is witnessing a significant rise in sports participation, contributing to increased sports-related injuries. As more individuals engage in various athletic activities, the need for effective injury management and prevention has become more pressing.
According to a January 2024 report by the NIH, the 1-year prevalence of sports injuries among Japanese collegiate athletes was 50.01%, with 5,500 injuries reported out of 10,998 athletes. The prevalence of injuries was notably higher in males at 52.02% compared to females at 46.65%. This growing demand is driving the blood-based biomarker for sports medicine market growth.
Blood-based biomarkers are gaining traction in Japan as essential tools for monitoring athlete health, detecting injuries early, and optimizing recovery processes. The market for these biomarkers is experiencing robust growth, supported by advancements in medical technology and increased research efforts. Companies are investing in innovative solutions to enhance diagnostic accuracy and tailor personalized treatment plans for athletes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Japan Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
